Activation of Nrf2 decreases bile acid concentrations in livers of female mice

References

• Aleksunes, L.M., et al., 2010. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. The journal of pharmacology and experimental therapeutics, 335 (1), 2–12.
   PubMed Web of Science ®Google Scholar
• Alnouti, Y., Csanaky, I.L., and Klaassen, C.D., 2008. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 873 (2), 209–217.
   PubMed Web of Science ®Google Scholar
• Bataille, A.M. and Manautou, J.E., 2012. Nrf2: a potential target for new therapeutics in liver disease. Clinical pharmacology and therapeutics, 92 (3), 340–348.
   PubMed Web of Science ®Google Scholar
• Bennion, L.J., et al., 1978. Sex differences in the size of bile acid pools. Metabolism: clinical and experimental, 27 (8), 961–969.
   PubMed Web of Science ®Google Scholar
• Carino, A., et al., 2020. Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis. Biochimica et biophysica acta. Molecular and cell biology of lipids, 1865 (9), 158733.
   PubMed Web of Science ®Google Scholar
• Cuadrado, A., et al., 2019. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature reviews. Drug discovery, 18 (4), 295–317.
   PubMed Web of Science ®Google Scholar
• Cullinan, S.B., et al., 2004. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Molecular and cellular biology, 24 (19), 8477–8486.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova, A.T., et al., 2005. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proceedings of the National Academy of Sciences of the United States of America, 102 (12), 4584–4589.
   PubMed Web of Science ®Google Scholar
• Frommherz, L., et al., 2016. Age-related changes of plasma bile acid concentrations in healthy adults-results from the cross-sectional KarMeN study. PLoS One, 11 (4), e0153959.
   PubMed Web of Science ®Google Scholar
• Jobbagy, S., et al., 2020. Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus. JCI Insight, 5 (1), e128578.
   PubMed Web of Science ®Google Scholar
• Kamisako, T., et al., 2014. Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice. Journal of clinical biochemistry and nutrition, 54 (2), 90–94.
   PubMed Web of Science ®Google Scholar
• Kensler, T.W., Wakabayashi, N., and Biswal, S., 2007. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual review of pharmacology and toxicology, 47, 89–116.
   PubMed Web of Science ®Google Scholar
• Khambu, B., et al., 2019. Hepatic autophagy deficiency compromises farnesoid X receptor functionality and causes cholestatic injury. Hepatology (Baltimore, Md.), 69 (5), 2196–2213.
   PubMed Web of Science ®Google Scholar
• Kim, J., et al., 2019. Effects of hepatic ischemia-reperfusion injuries and NRF2 on transcriptional activities of bile transporters in rats. Journal of surgical research, 235, 73–82.
   PubMed Web of Science ®Google Scholar
• Kobayashi, M. and Yamamoto, M., 2006. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advances in enzyme regulation, 46, 113–140.
   PubMedGoogle Scholar
• Li, T., et al., 2010. Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology (Baltimore, Md.), 52 (2), 678–690.
   PubMed Web of Science ®Google Scholar
• Lickteig, A.J., et al., 2016. Activation of constitutive androstane receptor (CAR) in mice results in maintained biliary excretion of bile acids despite a marked decrease of bile acids in liver. Toxicological sciences: An official journal of the Society of Toxicology, 151 (2), 403–418.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2013. Nrf2 protection against liver injury produced by various hepatotoxicants. Oxidative medicine and cellular longevity, 2013, 305861.
   PubMed Web of Science ®Google Scholar
• Maher, J.M., et al., 2007. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology (Baltimore, Md.), 46 (5), 1597–1610.
   PubMed Web of Science ®Google Scholar
• Reisman, S.A., et al., 2009. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. Toxicology and applied pharmacology, 236 (1), 109–114.
   PubMed Web of Science ®Google Scholar
• Rooney, J., et al., 2018. Activation of Nrf2 in the liver is associated with stress resistance mediated by suppression of the growth hormone-regulated STAT5b transcription factor. Plos one, 13 (8), e0200004.
   PubMed Web of Science ®Google Scholar
• Shen, G. and Kong, A.-N., 2009. Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharmaceutics & drug disposition, 30 (7), 345–355.
   PubMed Web of Science ®Google Scholar
• Trottier, J., et al., 2011. Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate. Clinical pharmacology and therapeutics, 90 (2), 279–286.
   PubMed Web of Science ®Google Scholar
• Weerachayaphorn, J., et al., 2009. Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression. Hepatology (Baltimore, Md.), 50 (5), 1588–1596.
   PubMed Web of Science ®Google Scholar
• Wu, K.C., Cui, J.Y., and Klaassen, C.D., 2011. Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicological sciences: An official journal of the Society of Toxicology, 123 (2), 590–600.
   PubMed Web of Science ®Google Scholar
• Wu, K.C., Cui, J.Y., and Klaassen, C.D., 2012. Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver. Plos one, 7 (7), e39006.
   PubMed Web of Science ®Google Scholar
• Xiang, X., et al., 2012. Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings. Basic & clinical pharmacology & toxicology, 110 (3), 245–252.
   PubMed Web of Science ®Google Scholar
• Xu, Y.Q., et al., 2012. Diurnal variation of hepatic antioxidant gene expression in mice. Plos one, 7 (8), e44237.
   PubMed Web of Science ®Google Scholar
• Yates, M.S., et al., 2007. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Molecular cancer therapeutics, 6 (1), 154–162.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. and Klaassen, C.D., 2010. Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice. Journal of lipid research., 51, 13.
   Web of Science ®Google Scholar
• Zhang, Y., et al., 2020. Effects of ablation and activation of Nrf2 on bile acid homeostasis in male mice. Toxicology and applied pharmacology, 403, 115170.
   PubMed Web of Science ®Google Scholar